IO Biotech's cancer vaccine Cylembio failed to hit the mark in a phase 3 melanoma trial – but the company hopes to file for approval regardless. The company said that the study "narrowly missed" the ...
Lawrence Pines 25+ years of experience as an equity and foreign exchange options trader. He launched his own consulting firm in 2011. David Kindness is a Certified Public Accountant (CPA) and an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback